Evidence map›Paper›PMID 30803481›Full record

ArticleeLife2019

Synergy and remarkable specificity of antimicrobial peptides in vivo using a systematic knockout approach.

Mark Austin Hanson, Anna Dostálová, Camilla Ceroni, Mickael Poidevin, Shu Kondo, Bruno Lemaitre

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 152 papers.

0numbers the graph read from it
0cells of the map it votes in
152citing papers in PubMed
22.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

152 citing papers in PubMed, 279 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Sketching microprotein portraits.Protein science : a publication of the Protein Society · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. α2-macroglobulin function of thioester-containing proteins guardsProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  12. Article
  13. Distinct roles of theCurrent research in insect science · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

92 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Mark Austin HansonGlobal Health Institute, School of Life Science, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.ORCID 0000-0002-6125-3672
Anna DostálováGlobal Health Institute, School of Life Science, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Camilla CeroniGlobal Health Institute, School of Life Science, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Mickael PoidevinInstitute for Integrative Biology of the Cell (I2BC), Université Paris-Saclay, CEA, CNRS, Université Paris Sud, Gif-sur-Yvette, France.
Shu KondoInvertebrate Genetics Laboratory, Genetic Strains Research Center, National Institute of Genetics, Mishima, Japan.
Bruno LemaitreGlobal Health Institute, School of Life Science, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.ORCID 0000-0001-7970-1667
École Polytechnique Fédérale de Lausanne · CHNational Institute of Genetics · JPUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) are host-encoded antibiotics that combat invading microorganisms. These short, cationic peptides have been implicated in many biological processes, primarily involving innate immunity. In vitro studies have shown AMPs kill bacteria and fungi at physiological concentrations, but little validation has been done in vivo. We utilized CRISPR gene editing to delete all known immune-inducible AMPs of

Indexed as

Immunity, InnateAnimalsAnti-Infective AgentsAntimicrobial Cationic PeptidesBacteriaDrosophilaFungiGene DeletionGene Knockout TechniquesAnti-Infective AgentsAntimicrobial Cationic PeptidesAMPDiptericinD. melanogasterDrosocinImdimmunologyinflammationsystemic immunityToll

Identifiers

PMID30803481
PMCPMC6398976
OpenAlexW2904897241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.